365betÌåÓýÔÚÏßÊÀ½ç±­

Skip to main content
You have permission to edit this article.
Edit

Medicine companies brace for tariffs, while weighing additional concern

FILE PHOTO: Illustration shows U.S. dollar banknote and medicines

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they grapple with the threat of sector-specific tariffs, efforts to lower drug prices and federal layoffs that could undermine efforts to invest heavily in the U.S. in coming years.

Large companies mostly have been immune to trade turmoil. Bristol Myers Squibb, Merck & Co, Sanofi and Roche all exceeded quarterly earnings expectations on Thursday, and Bristol raised its profit forecast.





Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News

Breaking News (FlagLive!)